Trinity Biotech Plc (TRIB)

Trinity Biotech (TRIB) Stock Price & Analysis


TRIB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.80 - $1.50
Previous Close$1.04
Average Volume (3M)40.95K
Market Cap
Enterprise Value$77.35M
Total Cash (Recent Filing)$6.58M
Total Debt (Recent Filing)$44.30M
Price to Earnings (P/E)-0.8
Jul 20, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.28
Shares Outstanding38,210,000
10 Day Avg. Volume24,848
30 Day Avg. Volume40,950
Standard Deviation0.23
Financial Highlights & Ratios
Price to Book (P/B)-0.98
Price to Sales (P/S)0.49
Price to Cash Flow (P/CF)4.00
P/FCF Ratio2.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.36
Enterprise Value/Gross Profit3.51
Enterprise Value/Ebitda-11.03
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Trinity Biotech Plc’s price range in the past 12 months?
Trinity Biotech Plc lowest stock price was $0.80 and its highest was $1.50 in the past 12 months.
    What is Trinity Biotech Plc’s market cap?
    Currently, no data Available
    When is Trinity Biotech Plc’s upcoming earnings report date?
    Trinity Biotech Plc’s upcoming earnings report date is Jul 20, 2023 which is in 40 days.
      How were Trinity Biotech Plc’s earnings last quarter?
      Currently, no data Available
      Is Trinity Biotech Plc overvalued?
      According to Wall Street analysts Trinity Biotech Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Trinity Biotech Plc pay dividends?
        Trinity Biotech Plc pays a Annually dividend of $0.22 which represents an annual dividend yield of N/A. See more information on Trinity Biotech Plc dividends here
          What is Trinity Biotech Plc’s EPS estimate?
          Trinity Biotech Plc’s EPS estimate is -$0.06.
            How many shares outstanding does Trinity Biotech Plc have?
            Trinity Biotech Plc has 38,207,570 shares outstanding.
              What happened to Trinity Biotech Plc’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Trinity Biotech Plc?
              Among the largest hedge funds holding Trinity Biotech Plc’s share is Stonehill Capital Management Llc. It holds Trinity Biotech Plc’s shares valued at 1M.


                Trinity Biotech Stock Smart Score

                The Trinity Biotech stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Trinity Biotech Plc

                Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.


                Forecast EPS vs Actual EPS

                Currently, no data available
                Please return soon. This page is being updated.

                Similar Stocks
                Price & Change
                Vascular Biogenics
                Onconova Therapeutics
                Viveve Medical

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis